APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vitamin and Derivative

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vitamin and Derivative Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchVitamin and Derivative Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Vitamin and Derivative Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Vitamin and Derivative Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vitamin and Derivative Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vitamin and Derivative Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Vitamin and Derivative market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vitamin and Derivative include Lonza Group, Pfizer, Bayer, ParkAcre Enterprises, Nutrilo, DuPont, DSM, BASF and Amway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vitamin and Derivative market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vitamin and Derivative and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vitamin and Derivative sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin and Derivative market size, projected growth trends, production technologies, key applications, and end-use industries.

Vitamin and Derivative Segment by Company

Lonza Group

Pfizer

Bayer

ParkAcre Enterprises

Nutrilo

DuPont

DSM

BASF

Amway

Aland Nutraceutical

AIE Pharmaceuticals

Adisseo France S.A.A

Vitamin and Derivative Segment by Type

Vitamin and Derivative Capsules

Vitamin and Derivative Powder

Vitamin and Derivative Tablets

Vitamin and Derivative Segment by Application

Pharmaceuticals

Food and Beverages

Dietary Supplements

Personal Care

Others

Vitamin and Derivative Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin and Derivative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vitamin and Derivative and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin and Derivative.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vitamin and Derivative market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vitamin and Derivative manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vitamin and Derivative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vitamin and Derivative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vitamin and Derivative Industry Trends Table 2. Vitamin and Derivative Industry Drivers Table 3. Vitamin and Derivative Industry Opportunities and Challenges Table 4. Vitamin and Derivative Industry Restraints Table 5. Global Vitamin and Derivative Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vitamin and Derivative Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vitamin and Derivative Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Vitamin and Derivative Sales Market Share by Manufacturers Table 9. Global Vitamin and Derivative Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Vitamin and Derivative Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vitamin and Derivative Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vitamin and Derivative Manufacturers, Product Type & Application Table 13. Global Vitamin and Derivative Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vitamin and Derivative by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vitamin and Derivative Capsules Table 17. Major Manufacturers of Vitamin and Derivative Powder Table 18. Major Manufacturers of Vitamin and Derivative Tablets Table 19. Global Vitamin and Derivative Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Vitamin and Derivative Sales by Type (2021-2026) & (K Units) Table 21. Global Vitamin and Derivative Sales by Type (2027-2032) & (K Units) Table 22. Global Vitamin and Derivative Sales Market Share by Type (2021-2026) Table 23. Global Vitamin and Derivative Sales Market Share by Type (2027-2032) Table 24. Global Vitamin and Derivative Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Vitamin and Derivative Revenue by Type (2021-2026) & (K Units) Table 26. Global Vitamin and Derivative Revenue by Type (2027-2032) & (K Units) Table 27. Global Vitamin and Derivative Revenue Market Share by Type (2021-2026) Table 28. Global Vitamin and Derivative Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pharmaceuticals Table 30. Major Manufacturers of Food and Beverages Table 31. Major Manufacturers of Dietary Supplements Table 32. Major Manufacturers of Personal Care Table 33. Major Manufacturers of Others Table 34. Global Vitamin and Derivative Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Vitamin and Derivative Sales by Application (2021-2026) & (K Units) Table 36. Global Vitamin and Derivative Sales by Application (2027-2032) & (K Units) Table 37. Global Vitamin and Derivative Sales Market Share by Application (2021-2026) Table 38. Global Vitamin and Derivative Sales Market Share by Application (2027-2032) Table 39. Global Vitamin and Derivative Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Vitamin and Derivative Revenue by Application (2021-2026) & (K Units) Table 41. Global Vitamin and Derivative Revenue by Application (2027-2032) & (K Units) Table 42. Global Vitamin and Derivative Revenue Market Share by Application (2021-2026) Table 43. Global Vitamin and Derivative Revenue Market Share by Application (2027-2032) Table 44. Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Vitamin and Derivative Sales by Region (2021-2026) & (K Units) Table 46. Global Vitamin and Derivative Sales Market Share by Region (2021-2026) Table 47. Global Vitamin and Derivative Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Vitamin and Derivative Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Vitamin and Derivative Sales by Country (2021-2026) & (K Units) Table 51. North America Vitamin and Derivative Sales by Country (2027-2032) & (K Units) Table 52. Europe Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Vitamin and Derivative Sales by Country (2021-2026) & (K Units) Table 54. Europe Vitamin and Derivative Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Vitamin and Derivative Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Vitamin and Derivative Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Vitamin and Derivative Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Vitamin and Derivative Sales by Country (2027-2032) & (K Units) Table 61. Global Vitamin and Derivative Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Vitamin and Derivative Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Vitamin and Derivative Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Vitamin and Derivative Revenue Market Share by Region (2021-2026) Table 65. Global Vitamin and Derivative Revenue Market Share by Region (2027-2032) Table 66. Lonza Group Company Information Table 67. Lonza Group Business Overview Table 68. Lonza Group Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Lonza Group Vitamin and Derivative Product Portfolio Table 70. Lonza Group Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Vitamin and Derivative Product Portfolio Table 75. Pfizer Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Bayer Vitamin and Derivative Product Portfolio Table 80. Bayer Recent Development Table 81. ParkAcre Enterprises Company Information Table 82. ParkAcre Enterprises Business Overview Table 83. ParkAcre Enterprises Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. ParkAcre Enterprises Vitamin and Derivative Product Portfolio Table 85. ParkAcre Enterprises Recent Development Table 86. Nutrilo Company Information Table 87. Nutrilo Business Overview Table 88. Nutrilo Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Nutrilo Vitamin and Derivative Product Portfolio Table 90. Nutrilo Recent Development Table 91. DuPont Company Information Table 92. DuPont Business Overview Table 93. DuPont Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. DuPont Vitamin and Derivative Product Portfolio Table 95. DuPont Recent Development Table 96. DSM Company Information Table 97. DSM Business Overview Table 98. DSM Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. DSM Vitamin and Derivative Product Portfolio Table 100. DSM Recent Development Table 101. BASF Company Information Table 102. BASF Business Overview Table 103. BASF Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. BASF Vitamin and Derivative Product Portfolio Table 105. BASF Recent Development Table 106. Amway Company Information Table 107. Amway Business Overview Table 108. Amway Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Amway Vitamin and Derivative Product Portfolio Table 110. Amway Recent Development Table 111. Aland Nutraceutical Company Information Table 112. Aland Nutraceutical Business Overview Table 113. Aland Nutraceutical Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Aland Nutraceutical Vitamin and Derivative Product Portfolio Table 115. Aland Nutraceutical Recent Development Table 116. AIE Pharmaceuticals Company Information Table 117. AIE Pharmaceuticals Business Overview Table 118. AIE Pharmaceuticals Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. AIE Pharmaceuticals Vitamin and Derivative Product Portfolio Table 120. AIE Pharmaceuticals Recent Development Table 121. Adisseo France S.A.A Company Information Table 122. Adisseo France S.A.A Business Overview Table 123. Adisseo France S.A.A Vitamin and Derivative Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Adisseo France S.A.A Vitamin and Derivative Product Portfolio Table 125. Adisseo France S.A.A Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Vitamin and Derivative Distributors List Table 129. Vitamin and Derivative Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Vitamin and Derivative Product Image Figure 2. Global Vitamin and Derivative Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vitamin and Derivative Market Size (2021-2032) & (US$ Million) Figure 4. Global Vitamin and Derivative Sales (2021-2032) & (K Units) Figure 5. Global Vitamin and Derivative Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Vitamin and Derivative Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vitamin and Derivative Capsules Image Figure 9. Vitamin and Derivative Powder Image Figure 10. Vitamin and Derivative Tablets Image Figure 11. Global Vitamin and Derivative Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Vitamin and Derivative Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Vitamin and Derivative Sales Market Share by Type (2021-2032) Figure 14. Global Vitamin and Derivative Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Vitamin and Derivative Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Vitamin and Derivative Revenue Market Share by Type (2021-2032) Figure 17. Pharmaceuticals Image Figure 18. Food and Beverages Image Figure 19. Dietary Supplements Image Figure 20. Personal Care Image Figure 21. Others Image Figure 22. Global Vitamin and Derivative Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Vitamin and Derivative Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Vitamin and Derivative Sales Market Share by Application (2021-2032) Figure 25. Global Vitamin and Derivative Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Vitamin and Derivative Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Vitamin and Derivative Revenue Market Share by Application (2021-2032) Figure 28. North America Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Vitamin and Derivative Sales Market Share by Country (2021-2032) Figure 30. U.S. Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Vitamin and Derivative Sales Market Share by Country (2021-2032) Figure 35. Germany Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Vitamin and Derivative Sales Market Share by Country (2021-2032) Figure 42. China Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Vitamin and Derivative Sales Market Share by Country (2021-2032) Figure 50. Brazil Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Vitamin and Derivative Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Vitamin and Derivative Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Vitamin and Derivative Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Vitamin and Derivative Revenue (2021-2032) & (US$ Million) Figure 61. North America Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Vitamin and Derivative Revenue (2021-2032) & (US$ Million) Figure 63. Europe Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Vitamin and Derivative Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Vitamin and Derivative Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Vitamin and Derivative Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Vitamin and Derivative Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamin and Derivative Capsules
  • Vitamin and Derivative Powder
  • Vitamin and Derivative Tablets
Applications
  • Pharmaceuticals
  • Food and Beverages
  • Dietary Supplements
  • Personal Care
  • Others
Companies covered
  • Lonza Group
  • Pfizer
  • Bayer
  • ParkAcre Enterprises
  • Nutrilo
  • DuPont
  • DSM
  • BASF
  • Amway
  • Aland Nutraceutical
  • AIE Pharmaceuticals
  • Adisseo France S.A.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vitamin and Derivative Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vitamin and Derivative Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vitamin and Derivative Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vitamin and Derivative Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vitamin and Derivative Market Dynamics
  1. 2.1 Vitamin and Derivative Industry Trends
  2. 2.2 Vitamin and Derivative Industry Drivers
  3. 2.3 Vitamin and Derivative Industry Opportunities and Challenges
  4. 2.4 Vitamin and Derivative Industry Restraints
3 Vitamin and Derivative Market by Manufacturers
  1. 3.1 Global Vitamin and Derivative Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vitamin and Derivative Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vitamin and Derivative Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vitamin and Derivative Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vitamin and Derivative Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vitamin and Derivative Manufacturers, Product Type & Application
  7. 3.7 Global Vitamin and Derivative Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vitamin and Derivative Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vitamin and Derivative Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vitamin and Derivative Tier 1, Tier 2, and Tier 3
4 Vitamin and Derivative Market by Type
  1. 4.1 Vitamin and Derivative Type Introduction
  2. 4.1.1 Vitamin and Derivative Capsules
  3. 4.1.2 Vitamin and Derivative Powder
  4. 4.1.3 Vitamin and Derivative Tablets
  5. 4.2 Global Vitamin and Derivative Sales by Type
  6. 4.2.1 Global Vitamin and Derivative Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vitamin and Derivative Sales by Type (2021-2032)
  8. 4.2.3 Global Vitamin and Derivative Sales Market Share by Type (2021-2032)
  9. 4.3 Global Vitamin and Derivative Revenue by Type
  10. 4.3.1 Global Vitamin and Derivative Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vitamin and Derivative Revenue by Type (2021-2032)
  12. 4.3.3 Global Vitamin and Derivative Revenue Market Share by Type (2021-2032)
5 Vitamin and Derivative Market by Application
  1. 5.1 Vitamin and Derivative Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Food and Beverages
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Personal Care
  6. 5.1.5 Others
  7. 5.2 Global Vitamin and Derivative Sales by Application
  8. 5.2.1 Global Vitamin and Derivative Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Vitamin and Derivative Sales by Application (2021-2032)
  10. 5.2.3 Global Vitamin and Derivative Sales Market Share by Application (2021-2032)
  11. 5.3 Global Vitamin and Derivative Revenue by Application
  12. 5.3.1 Global Vitamin and Derivative Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Vitamin and Derivative Revenue by Application (2021-2032)
  14. 5.3.3 Global Vitamin and Derivative Revenue Market Share by Application (2021-2032)
6 Global Vitamin and Derivative Sales by Region
  1. 6.1 Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vitamin and Derivative Sales by Region (2021-2032)
  3. 6.2.1 Global Vitamin and Derivative Sales by Region (2021-2026)
  4. 6.2.2 Global Vitamin and Derivative Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vitamin and Derivative Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vitamin and Derivative Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vitamin and Derivative Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vitamin and Derivative Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vitamin and Derivative Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vitamin and Derivative Revenue by Region
  1. 7.1 Global Vitamin and Derivative Revenue by Region
  2. 7.1.1 Global Vitamin and Derivative Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vitamin and Derivative Revenue by Region (2021-2026)
  4. 7.1.3 Global Vitamin and Derivative Revenue by Region (2027-2032)
  5. 7.1.4 Global Vitamin and Derivative Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vitamin and Derivative Revenue (2021-2032)
  8. 7.2.2 North America Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vitamin and Derivative Revenue (2021-2032)
  11. 7.3.2 Europe Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vitamin and Derivative Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vitamin and Derivative Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vitamin and Derivative Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza Group
  2. 8.1.1 Lonza Group Company Information
  3. 8.1.2 Lonza Group Business Overview
  4. 8.1.3 Lonza Group Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Group Vitamin and Derivative Product Portfolio
  6. 8.1.5 Lonza Group Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Vitamin and Derivative Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Vitamin and Derivative Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 ParkAcre Enterprises
  20. 8.4.1 ParkAcre Enterprises Company Information
  21. 8.4.2 ParkAcre Enterprises Business Overview
  22. 8.4.3 ParkAcre Enterprises Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ParkAcre Enterprises Vitamin and Derivative Product Portfolio
  24. 8.4.5 ParkAcre Enterprises Recent Developments
  25. 8.5 Nutrilo
  26. 8.5.1 Nutrilo Company Information
  27. 8.5.2 Nutrilo Business Overview
  28. 8.5.3 Nutrilo Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nutrilo Vitamin and Derivative Product Portfolio
  30. 8.5.5 Nutrilo Recent Developments
  31. 8.6 DuPont
  32. 8.6.1 DuPont Company Information
  33. 8.6.2 DuPont Business Overview
  34. 8.6.3 DuPont Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DuPont Vitamin and Derivative Product Portfolio
  36. 8.6.5 DuPont Recent Developments
  37. 8.7 DSM
  38. 8.7.1 DSM Company Information
  39. 8.7.2 DSM Business Overview
  40. 8.7.3 DSM Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 DSM Vitamin and Derivative Product Portfolio
  42. 8.7.5 DSM Recent Developments
  43. 8.8 BASF
  44. 8.8.1 BASF Company Information
  45. 8.8.2 BASF Business Overview
  46. 8.8.3 BASF Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BASF Vitamin and Derivative Product Portfolio
  48. 8.8.5 BASF Recent Developments
  49. 8.9 Amway
  50. 8.9.1 Amway Company Information
  51. 8.9.2 Amway Business Overview
  52. 8.9.3 Amway Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Amway Vitamin and Derivative Product Portfolio
  54. 8.9.5 Amway Recent Developments
  55. 8.10 Aland Nutraceutical
  56. 8.10.1 Aland Nutraceutical Company Information
  57. 8.10.2 Aland Nutraceutical Business Overview
  58. 8.10.3 Aland Nutraceutical Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aland Nutraceutical Vitamin and Derivative Product Portfolio
  60. 8.10.5 Aland Nutraceutical Recent Developments
  61. 8.11 AIE Pharmaceuticals
  62. 8.11.1 AIE Pharmaceuticals Company Information
  63. 8.11.2 AIE Pharmaceuticals Business Overview
  64. 8.11.3 AIE Pharmaceuticals Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AIE Pharmaceuticals Vitamin and Derivative Product Portfolio
  66. 8.11.5 AIE Pharmaceuticals Recent Developments
  67. 8.12 Adisseo France S.A.A
  68. 8.12.1 Adisseo France S.A.A Company Information
  69. 8.12.2 Adisseo France S.A.A Business Overview
  70. 8.12.3 Adisseo France S.A.A Vitamin and Derivative Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Adisseo France S.A.A Vitamin and Derivative Product Portfolio
  72. 8.12.5 Adisseo France S.A.A Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vitamin and Derivative Value Chain Analysis
  2. 9.1.1 Vitamin and Derivative Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vitamin and Derivative Production Mode & Process
  6. 9.2 Vitamin and Derivative Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vitamin and Derivative Distributors
  9. 9.2.3 Vitamin and Derivative Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst